NASDAQ: NVEC

NVE CORP /NEW/

CIK 0000724910 · SIC 3674 · Semiconductors

Micro Revenue $26M Assets $62M as of Oct 18, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (AAL 10-Q) is open in full — no account needed.

10-Q Filed Oct 21, 2026 · Period ending Sep 30, 2026

Summary not yet generated.

8-K Filed Oct 21, 2026 · Period ending Oct 21, 2026

Summary not yet generated.

Partner

Trade NVEC commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Aug 10, 2026 · Period ending Aug 6, 2026

Summary not yet generated.

10-Q Filed Jul 22, 2026 · Period ending Jun 30, 2026

Summary not yet generated.

8-K Filed Jul 22, 2026 · Period ending Jul 22, 2026

Summary not yet generated.

8-K Filed Jun 22, 2026 · Period ending Jun 22, 2026

Summary not yet generated.

8-K Filed May 6, 2026 · Period ending May 6, 2026

Summary not yet generated.

10-K Filed May 6, 2026 · Period ending Mar 31, 2026

Summary not yet generated.

10-Q Filed Jan 21, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

10-K Filed May 7, 2025 · Period ending Mar 31, 2025

Summary not yet generated.

10-Q/A Filed Oct 15, 2018 · Period ending Sep 30, 2018

Summary not yet generated.

10-K/A Filed May 4, 2017 · Period ending Mar 31, 2017

Summary not yet generated.

Latest financial statements

From 10-Q filed Oct 21, 2026 (period ending Sep 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Statements of Income (Unaudited)

Description Quarter ended September 30, 2026 Quarter ended September 30, 2025
Revenue
Product sales 5,575,282 6,138,772
Contract research and development 259,420 208,220
Total revenue, net 5,834,702 6,346,992
Cost of sales 1,270,805 1,378,494
Gross profit 4,563,897 4,968,498
Expenses
Research and development 727,345 873,470
Selling, general, and administrative 630,314 436,919
Total expenses 1,357,659 1,310,389
Income from operations 3,206,238 3,658,109
Interest income 474,727 484,330
Other income - 3,094
Income before taxes 3,680,965 4,145,533
Provision for income taxes 507,806 834,695
Net income 3,173,159 3,310,838
Net income per share basic 0.66 0.68
Net income per share diluted 0.65 0.68
Cash dividends declared per common share 1.00 1.00
Weighted average shares outstanding
Basic 4,842,050 4,837,166
Diluted 4,850,910 4,839,243

Consolidated Balance Sheets (Unaudited)

(in millions, except per share amounts; mapped from filer XBRL tags, not printed on the filing face)

Description Sep 30, 2026 Mar 31, 2026
Current assets:
Cash and equivalents 4.0 1.7
Marketable securities 19.7 18.1
Accounts receivable, net 3.0 3.4
Inventories 6.9 7.1
Prepaid expenses and other current assets 1.5 1.9
Total current assets 35.1 32.2
Marketable securities, noncurrent 20.7 23.7
Property, plant and equipment, net 3.3 3.7
Operating lease right-of-use assets, net 0.7 0.8
Deferred income taxes and other assets —
TOTAL ASSETS 59.9 60.4
Current liabilities:
Accounts payable 0.3 0.3
Current portion of operating lease liabilities 0.2 0.2
Accrued liabilities 0.8 0.7
Total current liabilities 1.2 1.1
Operating lease liabilities 0.7 0.7
Deferred income taxes and other liabilities 0.01 0.2
Total liabilities 1.9 2.1
Shareholders' equity:
Common stock 0.05 0.05
Capital in excess of stated value 20.2 19.9
Accumulated other comprehensive income (loss) (0.5) (0.03)
Retained earnings (deficit) 38.2 38.3
Total shareholders' equity 58.0 58.2
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY 59.9 60.4

Statements of Cash Flows (Unaudited)

Description Six months ended September 30, 2026 Six months ended September 30, 2025
OPERATING ACTIVITIES
Net income 9,567,350 6,886,656
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation 464,522 174,451
Bonds discount amortization (44,753) (175,895)
Stock-based compensation 260,980 73,150
Deferred income taxes (120,640) 742,885
Non-cash operating lease expense 27,571 103,931
Changes in operating assets and liabilities:
Accounts receivable 403,013 1,148,412
Inventories 222,511 30,240
Prepaid expenses and other assets 318,932 (729,679)
Accounts payable (26,200) 14,835
Accrued payroll and other 54,084 (285,774)
Net cash provided by operating activities 11,127,370 7,983,212
INVESTING ACTIVITIES
Purchases of fixed assets (81,968) (1,128,981)
Purchases of marketable securities (8,108,071) (10,108,982)
Proceeds from maturities of marketable securities 9,000,000 10,000,000
Net cash provided by (used in) investing activities 809,961 (1,237,963)
FINANCING ACTIVITIES
Payments on exercise of stock options (168) -
Payment of dividends to shareholders (9,681,245) (9,674,332)
Net cash used in financing activities (9,681,413) (9,674,332)
Increase (decrease) in cash and cash equivalents 2,255,918 (2,929,083)
Cash and cash equivalents at beginning of period 1,714,040 8,036,564
Cash and cash equivalents at end of period 3,969,958 5,107,481
Supplemental disclosures of cash flow information:
Cash paid during the period for income taxes 1,641,360 1,680,555

Statements found on the EDGAR/iXBRL face print as filed; the rest are presentation-friendly mappings of filer XBRL tags, at the scale noted on each table. EPS as reported. Use EDGAR for interactive notes and detail. Interactive statements & notes on EDGAR ↗